Avadel Pharmaceuticals (AVDL) Share-based Compensation (2016 - 2022)
Historic Share-based Compensation for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Q4 2022 value amounting to $1.9 million.
- Avadel Pharmaceuticals' Share-based Compensation fell 3078.3% to $1.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $7.0 million, marking a year-over-year decrease of 2095.36%. This contributed to the annual value of $20.4 million for FY2024, which is 2894.19% up from last year.
- As of Q4 2022, Avadel Pharmaceuticals' Share-based Compensation stood at $1.9 million, which was down 3078.3% from $1.9 million recorded in Q3 2022.
- Over the past 5 years, Avadel Pharmaceuticals' Share-based Compensation peaked at $2.8 million during Q3 2018, and registered a low of -$229000.0 during Q3 2019.
- In the last 5 years, Avadel Pharmaceuticals' Share-based Compensation had a median value of $1.5 million in 2020 and averaged $1.4 million.
- Per our database at Business Quant, Avadel Pharmaceuticals' Share-based Compensation plummeted by 10808.62% in 2019 and then skyrocketed by 129818.18% in 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Share-based Compensation (Quarter) stood at $662000.0 in 2018, then crashed by 48.34% to $342000.0 in 2019, then surged by 278.36% to $1.3 million in 2020, then soared by 115.15% to $2.8 million in 2021, then tumbled by 30.78% to $1.9 million in 2022.
- Its Share-based Compensation stands at $1.9 million for Q4 2022, versus $1.9 million for Q3 2022 and $658000.0 for Q2 2022.